About
WG5 aims to develop new therapeutic approaches in radiotherapy (RT). Novel pathological grading strategies combine radiomics and multimodal -omics techniques for RT. The distinguishing of low-risk-of-growth (LRG) and high-risk-of-growth (HRG) patients is central; a “Wait and See” strategy can be applied directly to LRG patients.
Research focus
Clinical Treatment Recommendations
WG5 aims to develop new therapeutic approaches in radiotherapy (RT). Novel pathological grading strategies combine radiomics and multimodal -omics techniques for RT. The distinguishing of low-risk-of-growth (LRG) and high-risk-of-growth (HRG) patients is central; a “Wait and See” strategy can be applied directly to LRG patients.